Cerebral radiation necrosis: A review of the pathobiology, diagnosis and management considerations

被引:163
作者
Rahmathulla, Gazanfar [1 ,2 ,3 ]
Marko, Nicholas F. [4 ]
Weil, Robert J. [1 ,2 ,3 ]
机构
[1] Cleveland Clin, Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44195 USA
[3] Cleveland Clin, Neurol Inst, Cleveland, OH 44195 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
关键词
Radiation necrosis; Pathophysiology; Diagnosis; Management options; Recent advances; CENTRAL-NERVOUS-SYSTEM; RECURRENT BRAIN-TUMOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VITRO RADIOSENSITIVITY; HYPERBARIC-OXYGEN THERAPY; GAMMA-KNIFE RADIOSURGERY; NORMAL TISSUE-REACTIONS; ATM SEQUENCE VARIANTS; INTERSTITIAL BRACHYTHERAPY;
D O I
10.1016/j.jocn.2012.09.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Radiation therapy forms one of the building blocks of the multi-disciplinary management of patients with brain tumors. Improved survival following radiation therapy may come with a cost, including the potential complication of radiation necrosis. Radiation necrosis impacts the quality of life in cancer survivors, and it is essential to detect and effectively treat this entity as early as possible. Significant progress in neuro-radiology and molecular pathology facilitate more straightforward diagnosis and characterization of cerebral radiation necrosis. Several therapeutic interventions, both medical and surgical, may halt the progression of radiation necrosis and diminish or abrogate its clinical manifestations, but there are still no definitive guidelines to follow explicitly that guide treatment of radiation necrosis. We discuss the pathobiology, clinical features, diagnosis, available treatment modalities, and outcomes in the management of patients with intracranial radiation necrosis that follows radiation used to treat brain tumors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:485 / 502
页数:18
相关论文
共 230 条
[1]   Wound heating morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-β activity [J].
Akudugu , JM ;
Bell, RS ;
Catton, C ;
Davis, AM ;
Griffin, AM ;
O'Sullivan, B ;
Waldron, JN ;
Ferguson, PC ;
Wunder, JS ;
Hill, RP .
RADIOTHERAPY AND ONCOLOGY, 2006, 78 (01) :17-26
[2]   Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities [J].
Alexiou, George A. ;
Tsiouris, Spyridon ;
Kyritsis, Athanasios P. ;
Voulgaris, Spyridon ;
Argyropoulou, Maria I. ;
Fotopoulos, Andreas D. .
JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (01) :1-11
[3]   Genetic markers for prediction of normal tissue toxicity after radiotherapy [J].
Alsner, Jan ;
Andreassen, Christian Nicolaj ;
Overgaard, Jens .
SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (02) :126-135
[4]   Radiosensitivity in Fanconi's anemia patients [J].
Alter, BP .
RADIOTHERAPY AND ONCOLOGY, 2002, 62 (03) :345-347
[5]   Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study [J].
Ambrosone, Christine B. ;
Tian, Chunqiao ;
Ahn, Jiyoung ;
Kropp, Silke ;
Helmbold, Irmgard ;
von Fournier, Dietrich ;
Haase, Wulf ;
Sautter-Bihl, Marie Luise ;
Wenz, Frederik ;
Chang-Claude, Jenny .
BREAST CANCER RESEARCH, 2006, 8 (04)
[6]   Genetic variants and normal tissue toxicity after radiotherapy: A systematic review [J].
Andreassen, Christian Nicolaj ;
Alsner, Jan .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (03) :299-309
[7]   ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy [J].
Andreassen, CN ;
Overgaard, J ;
Alsner, J ;
Overgaard, M ;
Herskind, C ;
Cesaretti, JA ;
Atencio, DP ;
Green, S ;
Formenti, SC ;
Stock, RG ;
Rosenstein, BS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (03) :776-783
[8]   Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? [J].
Andreassen, CN ;
Alsner, J ;
Overgaard, J .
RADIOTHERAPY AND ONCOLOGY, 2002, 64 (02) :131-140
[9]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[10]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491